Month: December 2019
-
Science & Enterprise Year in Review
Our most-viewed new story is from an academic/industry research team in Australia that tells how a synthetic cannabidiol, or CBD, compound is as effective as current antibiotics against a class of microbes.
-
Life Insurance Myths You Need To Stop Believing
Use life insurance to give you peace of mind in knowing that your family will be provided for after you’re gone.
-
Ingested X-Ray Capsule Shown Safe, Feasible
Results from a small-scale clinical trial show an ingested capsule to diagnose potential colon tumors is safe and feasible for most patients.
-
Infographic – Biotech Index Zooms to New High
Since October, the Nasdaq Biotechnology Index rose steadily to a new high for the year, as shown in this weekend’s infographic.
-
Tech Is Improving Logistics For Businesses
It’s crucial that if you are operating in the logistics industry, you are not left behind.
-
Synthetic Bio Cancer Immunotherapy Company Acquired
A biotechnology company creating synthetic proteins that invoke the immune system to fight cancer is being acquired by drug maker Astellas Pharma.
-
Commentary – New Models Needed for Antibiotic Resistance
Many parts of a new model for fighting antibiotic resistance are in development, and the pieces still need to be assembled, but the outline of a precision-medicine rather than mass-produced drug model is beginning to emerge.
-
Happy Holidays 2019
It’s Christmas day and a holiday in many countries around the world, including the U.S.
-
Tomato Genetics Altered for Urban Farms
Plant scientists used a genome-editing technique to produce varieties of tomatoes better suited for growing on urban farms and other small plots.
-
Climate Action Cost Accounting Standard Proposed
A new paper proposes an accounting standard that would require private companies to spell out their costs of meeting net-zero greenhouse gas emissions.